Omega Fund VI, L.P.

Omega Fund VI, L.P. has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Imago BioSciences, Inc., Lexeo Therapeutics, Inc. and Spruce Biosciences, Inc. The record holds 10 filings, for trades running from 14 October 2020 to 7 November 2023.

Every open-market trade on record is a purchase: 4 purchases worth €13.8M, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. In 2023 alone, the filings show 1 purchase and no sales.

Half of the purchases are above €3.3M and half below. 4 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The latest filing, published on 9 November 2023, reports a transaction in Lexeo Therapeutics, Inc. The last insider purchase was made public on 9 November 2023, 1,079 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.